Ginkgo biloba extract v placebo in mild to moderate Alzheimer's disease

Outcome at mean follow up of 19 weeksWeighted mean differenceControls with a worse outcome than treated*
*The proportion of control patients with a worse outcome than the average treated patient; calculated from data in article.
Cognitive function0.41 (0.22 to 0.61)66% (59 to 73)